This observational study is looking for specific genetic traits that might explain why people develop pulmonary fibrosis (scarring of the lungs) and how these traits affect the patterns of inflammation and scarring in the lungs. Researchers are collecting samples to understand the molecular causes of Idiopathic Pulmonary Fibrosis (IPF), a severe lung disease. You may be able to join if you are 18 or older, have a confirmed diagnosis of pulmonary fibrosis, and are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. The study aims to collect samples for up to 5 years to identify these genetic factors. This study does not involve any specific interventions or treatments.

Study design

This is an observational study aiming to enroll 2000 participants. It is not testing a specific drug or treatment.

What's involved

Sample collection will occur, and this process may continue for up to 5 years. The record does not specify the frequency or type of visits or procedures.

Compensation

Not stated in the trial record.

Follow-up

Sample collection will occur up to 5 years. The record does not specify follow-up after sample collection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.